Intravenous lorazepam in psychogenic catatonia

Electroconvulsive therapy in the very old.

General hospital psychiatry·1996

Delirium. Quick recognition, careful evaluation, and appropriate treatment.

Postgraduate medicine·1996

Adapting cognitive behavioral therapy for the frail elderly.

International psychogeriatrics·1995

Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman.

Southern medical journal·1994

Depression in the elderly.

Southern medical journal·1994

Obsessive-compulsive disorder. Characteristic features, pharmacologic management.

Postgraduate medicine·1992

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal of clinical psychopharmacology·2026

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Journal of clinical psychopharmacology·2026

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

Journal of clinical psychopharmacology·2026

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Journal of clinical psychopharmacology·2026

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Journal of clinical psychopharmacology·2026

Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.

Journal of clinical psychopharmacology·2026

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Pharmacological research·2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

Translational oncology·2026

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Materials today. Bio·2026

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Research square·2026

Mitochondrial Dysfunction in Ifosfamide-Induced Nephrotoxicity: Mechanisms and Possible Interventions.

European journal of pharmacology·2026

A direct comparison of butyrate, 4-phenylbutyrate, and β-hydroxybutyrate in an in vitro tumor therapy model.

Cancer treatment and research communications·2026

Related Experiment Videos

Intravenous lorazepam in psychogenic catatonia

Related Concept Videos

Electroconvulsive therapy in the very old.

Delirium. Quick recognition, careful evaluation, and appropriate treatment.

Adapting cognitive behavioral therapy for the frail elderly.

Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman.

Depression in the elderly.

Obsessive-compulsive disorder. Characteristic features, pharmacologic management.

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Mitochondrial Dysfunction in Ifosfamide-Induced Nephrotoxicity: Mechanisms and Possible Interventions.

A direct comparison of butyrate, 4-phenylbutyrate, and β-hydroxybutyrate in an in vitro tumor therapy model.

Related Experiment Videos

Intravenous lorazepam in psychogenic catatonia

Related Concept Videos

Related Articles